Marsh & McLennan Companies, Inc.

NYSE:MRSH

Insurance - Brokers

Financial Services
$205.43 -1.75%

-$2.87 today

Market cap
$98.03B
Beta
0.61
P/E (TTM)
19.9
EPS (TTM)
$8.11
Dividend yield
2.23%
52W Low $156.60High $220.32

Volume 1.40M

Average 3.00M

MRSH Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Marsh & McLennan Companies, Inc.NYSE: MRSH

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How MRSH compares with its peers on the latest reported figures

  • MRSH's LTM Sep 2026 research & development of $0 is the highest of the 7 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for MRSH, versus a peer median of 0.0%.
MRSH Competitors Peer median
Research & Development for MRSH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MRSHMarsh & McLennan Companies, Inc.LTM Sep 2026$0 ——0.0%
AJGArthur J. Gallagher & Co.LTM Jun 2026$0 ——0.0%
AONAon plcLTM Jun 2026$0 ——0.0%
WTWWillis Towers Watson Public Limited CompanyLTM Jun 2026$0 ——0.0%
BROBrown & Brown, Inc.LTM Sep 2026$0 ——0.0%
RYANRyan Specialty Holdings, Inc.LTM Jun 2026$0 ——0.0%
BWINThe Baldwin Insurance Group, Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding MRSH) $0——0.0%

Competitors are the stored peer set for MRSH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue19.82B20.72B22.74B24.46B26.98B
Cost of Revenue11.43B12.07B13.1B14B15.58B
Gross Profit8.4B8.65B9.64B10.46B11.4B
Gross Margin42.4%41.7%42.4%42.8%42.3%
Research & Development00000
Selling, General & Admin00000
Operating Expenses4.08B4.37B4.36B4.65B5.18B
Depreciation & Amortization747M719M713M746M910M
EBITDA5.4B5.27B6.32B6.93B7.4B
EBITDA Margin27.2%25.4%27.8%28.3%27.4%
Operating Income4.31B4.28B5.28B5.82B6.22B
Operating Margin21.8%20.7%23.2%23.8%23.1%
Interest Income2M15M78M83M48M
Interest Expense444M469M578M700M960M
Other Income / Expenses(104M)(198M)(256M)(337M)(684M)
Income Before Tax4.21B4.08B5.03B5.48B5.54B
Pre-Tax Margin21.2%19.7%22.1%22.4%20.5%
Income Tax Expense1.03B995M1.22B1.36B1.31B
Net Income3.14B3.05B3.76B4.06B4.16B
Net Margin15.9%14.7%16.5%16.6%15.4%
EPS (Basic)6.206.117.608.258.48
EPS (Diluted)6.136.047.538.188.43
Weighted Avg Shares507M499M494M492M487M
Weighted Avg Shares (Diluted)513M505M499M496M490M

Marsh & McLennan Companies, Inc.

NYSE:MRSH

Intrinsic Alpha fair value

Locked

Current Price

$205.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.